IMIDAZOPYRIMIDINYL AND IMIDAZOPYRIDINYL DERIVATIVES

Provided herein are compounds of the formula (I): as well as stereoisomers and pharmaceutically acceptable salts thereof. Such compounds are, because of their ability to antagonize CRF, useful in the treatment of a variety of disorders characterized by execssive CRF expression. These include, for ex...

Full description

Saved in:
Bibliographic Details
Main Authors WILDE, RICHARD, G, BAKTHAVATCHALAM, RAJAGOPAL, BECK, JAMES, P, ARVANITIS, ARGYRIOS
Format Patent
LanguageEnglish
French
German
Published 02.10.2002
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Provided herein are compounds of the formula (I): as well as stereoisomers and pharmaceutically acceptable salts thereof. Such compounds are, because of their ability to antagonize CRF, useful in the treatment of a variety of disorders characterized by execssive CRF expression. These include, for example: affective disorder, anxiety, depression, headache, irritable bowel syndrome, post-traumatic stress disorder, supranuclear palsy, immune suppression, Alzheimer's disease, Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis, gastrointestinal diseases, anorexia nervosa or other feeding disorder, drug addiction, drug or alcohol withdrawal symptoms, inflammatory diseases, cardiovascular or heart-related diseases, fertility problems, human immunodeficiency virus infections, hemorrhagic stress, obesity, infertility, head and spinal cord traumas, epilepsy, stroke, ulcers, amyotrophic lateral sclerosis and hypoglycemia.
AbstractList Provided herein are compounds of the formula (I): as well as stereoisomers and pharmaceutically acceptable salts thereof. Such compounds are, because of their ability to antagonize CRF, useful in the treatment of a variety of disorders characterized by execssive CRF expression. These include, for example: affective disorder, anxiety, depression, headache, irritable bowel syndrome, post-traumatic stress disorder, supranuclear palsy, immune suppression, Alzheimer's disease, Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis, gastrointestinal diseases, anorexia nervosa or other feeding disorder, drug addiction, drug or alcohol withdrawal symptoms, inflammatory diseases, cardiovascular or heart-related diseases, fertility problems, human immunodeficiency virus infections, hemorrhagic stress, obesity, infertility, head and spinal cord traumas, epilepsy, stroke, ulcers, amyotrophic lateral sclerosis and hypoglycemia.
Author ARVANITIS, ARGYRIOS
BECK, JAMES, P
BAKTHAVATCHALAM, RAJAGOPAL
WILDE, RICHARD, G
Author_xml – fullname: WILDE, RICHARD, G
– fullname: BAKTHAVATCHALAM, RAJAGOPAL
– fullname: BECK, JAMES, P
– fullname: ARVANITIS, ARGYRIOS
BookMark eNrjYmDJy89L5WQw9vT1dHGM8g-IDAKxPP0ifRQc_VwUkIQhgi6uQZ5hjiGeYa7BPAysaYk5xam8UJqbQcHNNcTZQze1ID8-tbggMTk1L7Uk3jXA0MjExMzMzNHQmAglAJyOKSs
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate DERIVES IMIDAZOPYRIMIDINYLES ET IMIDAZOPYRIDINYLES
IMIDAZOPYRIMIDINYL UND IMIDAZOPYRIDINYL DERIVATIVE
Edition 7
ExternalDocumentID EP1244666A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP1244666A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:55:56 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP1244666A13
Notes Application Number: EP20000991411
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20021002&DB=EPODOC&CC=EP&NR=1244666A1
ParticipantIDs epo_espacenet_EP1244666A1
PublicationCentury 2000
PublicationDate 20021002
PublicationDateYYYYMMDD 2002-10-02
PublicationDate_xml – month: 10
  year: 2002
  text: 20021002
  day: 02
PublicationDecade 2000
PublicationYear 2002
RelatedCompanies BRISTOL-MYERS SQUIBB PHARMA COMPANY
RelatedCompanies_xml – name: BRISTOL-MYERS SQUIBB PHARMA COMPANY
Score 2.564056
Snippet Provided herein are compounds of the formula (I): as well as stereoisomers and pharmaceutically acceptable salts thereof. Such compounds are, because of their...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title IMIDAZOPYRIMIDINYL AND IMIDAZOPYRIDINYL DERIVATIVES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20021002&DB=EPODOC&locale=&CC=EP&NR=1244666A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTYxTjMzS07WTUuytNQ1STI30E0ENlt1U0yB3YmURCMDU_Bdh75-Zh6hJl4RphFMDJmwvTDgc0LLwYcjAnNUMjC_l4DL6wLEIJYLeG1lsX5SJlAo394txNZFDdY7NgKdKKrm4mTrGuDv4u-s5uwMZKn5BdmCqjFgS90R2FFiBbWiQcfsu4Y5gTalFCDXKG6CDGwBQMPySoQYmFLzhBk4nWEXrwkzcPhC57uBTGjWKxZhMAaWMi6OUf4BkUEglqdfpI-Co5-LApIwRNAF2DULcwzxDHMNFmVQcHMNcfbQBdoeD_dpvGsA3J3GYgwsefl5qRIMCimpoEZ_oolBqqmxSbKFmWVaommKcbIx6PA0YG8sWZJBEqcxUnjkpBm4IHebGOgaGMkwsJQUlabKAqvYkiQ5cOAAABpKews
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401VhvWjXWJwfDjUhYoPZADGUhoLxSkbReGp5JL7SxGP--w7bUXvQ2mU1mH8k8vt2dGYAHIpNSVbNMKNPRSJDToSgkGLYKuYJwIk8kUWG9Dj1ftd_ll6ky7cCizYVhdUK_WXFE1KgM9b1m9nr1e4lF2d_K9WO6QNby2Yo0yrfoWGoqivJ0rJlhQAODNwykeH-iNW4MI3UdgdLBEBEhQ0rxuElKWe17FOsEDkMUVtWn0CmqPvSMtvFaH4687Xs3klvVW58BQStD9Y8gnE0ayvFnLqf7lNtjb5gUoVmsR05svp0DZ5mRYQs4-3y307kZ7tZJLqBbLaviEri8aIL-RBYLhcjZkzoqEyUnGWmKpyEaywYw-FPM1T9j99CzI8-du47_eg3Hmz4noiBKN9CtP7-KW3S3dXrHDuoHAHB99Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=IMIDAZOPYRIMIDINYL+AND+IMIDAZOPYRIDINYL+DERIVATIVES&rft.inventor=WILDE%2C+RICHARD%2C+G&rft.inventor=BAKTHAVATCHALAM%2C+RAJAGOPAL&rft.inventor=BECK%2C+JAMES%2C+P&rft.inventor=ARVANITIS%2C+ARGYRIOS&rft.date=2002-10-02&rft.externalDBID=A1&rft.externalDocID=EP1244666A1